Medifast (MED) Tax Provisions (2010 - 2026)

Medifast has reported Tax Provisions for 17 years, with the latest figure at $181000.0 in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions fell 86.08% year-over-year to $181000.0; the trailing twelve-month figure through Mar 2026 stood at $11.9 million (up 4760.78% YoY), and the FY2025 full-year result was $13.0 million, up 666.51% from the prior year.
• Tax Provisions for Q1 2026 stood at $181000.0, down from $11.7 million in the prior quarter.
• The five-year high for Tax Provisions was $13.4 million in Q1 2023, with the low at -$2.5 million in Q2 2024.
• Historically, Tax Provisions has averaged $5.0 million across 5 years, with a median of $3.4 million in 2023.
• The largest YoY upside for Tax Provisions was 2259.68% in 2025 against a maximum downside of 189.09% in 2025.
• Medifast's Tax Provisions stood at $5.9 million in 2022, then sank by 36.04% to $3.8 million in 2023, then sank by 86.83% to $496000.0 in 2024, then jumped by 2259.68% to $11.7 million in 2025, then tumbled by 98.45% to $181000.0 in 2026.
• The last three Tax Provisions figures came in at $181000.0 (Q1 2026), $11.7 million (Q4 2025), and -$400000.0 (Q3 2025), per Business Quant data.